KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jul 10, 2025 - 3:59PM >>  ABB India 5886.5  [ -0.22% ]  ACC 1999.75  [ 0.46% ]  Ambuja Cements 585.15  [ -0.95% ]  Asian Paints Ltd. 2450.8  [ -1.92% ]  Axis Bank Ltd. 1164.5  [ -0.02% ]  Bajaj Auto 8275.45  [ -0.99% ]  Bank of Baroda 238.8  [ -1.00% ]  Bharti Airtel 1965.1  [ -2.62% ]  Bharat Heavy Ele 261.25  [ -0.29% ]  Bharat Petroleum 350.7  [ 0.59% ]  Britannia Ind. 5884.45  [ 0.02% ]  Cipla 1478.25  [ -0.91% ]  Coal India 384.1  [ -0.89% ]  Colgate Palm. 2411.05  [ -1.09% ]  Dabur India 522.35  [ 0.04% ]  DLF Ltd. 829.8  [ 0.01% ]  Dr. Reddy's Labs 1259.2  [ -0.82% ]  GAIL (India) 185.7  [ 0.35% ]  Grasim Inds. 2775  [ -0.86% ]  HCL Technologies 1663.35  [ -0.64% ]  HDFC Bank 2002.05  [ -0.43% ]  Hero MotoCorp 4320.4  [ -0.33% ]  Hindustan Unilever L 2408  [ -0.60% ]  Hindalco Indus. 676.5  [ 0.43% ]  ICICI Bank 1424.5  [ -0.52% ]  Indian Hotels Co 743  [ -0.94% ]  IndusInd Bank 852.65  [ 1.41% ]  Infosys L 1616.75  [ -1.05% ]  ITC Ltd. 416.9  [ -0.58% ]  Jindal St & Pwr 942.75  [ -0.25% ]  Kotak Mahindra Bank 2218.9  [ -0.42% ]  L&T 3574  [ -0.11% ]  Lupin Ltd. 1899.85  [ -0.70% ]  Mahi. & Mahi 3161.75  [ -0.48% ]  Maruti Suzuki India 12638.6  [ 1.36% ]  MTNL 49.07  [ -0.89% ]  Nestle India 2401  [ -1.07% ]  NIIT Ltd. 127.7  [ -0.23% ]  NMDC Ltd. 68.62  [ 1.08% ]  NTPC 341.6  [ -0.64% ]  ONGC 243  [ -0.14% ]  Punj. NationlBak 109.7  [ -1.17% ]  Power Grid Corpo 299  [ -0.20% ]  Reliance Inds. 1517.2  [ -0.12% ]  SBI 808  [ -0.35% ]  Vedanta 438.95  [ -0.42% ]  Shipping Corpn. 224  [ -0.38% ]  Sun Pharma. 1663.7  [ -0.21% ]  Tata Chemicals 924.2  [ 0.16% ]  Tata Consumer Produc 1086  [ -1.04% ]  Tata Motors 695.5  [ 0.38% ]  Tata Steel 160.65  [ 1.04% ]  Tata Power Co. 399.8  [ -0.16% ]  Tata Consultancy 3382.3  [ -0.06% ]  Tech Mahindra 1600.15  [ -0.93% ]  UltraTech Cement 12480  [ -0.67% ]  United Spirits 1384  [ 0.96% ]  Wipro 265.1  [ -0.97% ]  Zee Entertainment En 141.9  [ 0.14% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

10 July 2025 | 03:59

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 159.80 Face Value 10.00
Bookclosure 26/09/2024 52Week High 630 EPS 5.24 P/E 74.51
Market Cap. 529.63 Cr. 52Week Low 375 P/BV / Div Yield (%) 2.44 / 0.26 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh.

MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales.

MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively.

2010

-The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share)

-The Company appointed Mr. B.K.Gupta as Managing Director.

2011

-The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan.

2013

-Ms. Harshita Sharma has been appointed as Additional Director of the company.

2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd.

2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant.

2020 -Global API Facility started Dahej API Plant.

2021 -Operations started Haridwar formulation Unit II(FDF).

2023 --Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024 -Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece. -Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.